FREQUENCY OF DIABETIC RETINOPATHY IN PATIENTS AFTER TEN YEARS OF DIAGNOSIS OF TYPE 2 DIABETES MELLITUS
Abstract
Background: Diabetic retinopathy is one of the most common and serious complications of type 2diabetes mellitus and a leading cause of blindness not only in Pakistan but also worldwide. So weconducted this study to record the frequency of diabetic retinopathy in known diabetic patients ten yearsafter diagnosis of type 2 diabetes mellitus. Methods: The study was conducted at Liaquat University ofMedical and Health Sciences, Jamshoro, Pakistan for a period of 1 year from January 2008 to January2010. The study group comprised of 200 patients of type 2 diabetes mellitus attending the medicalclinic. All patients who were diagnosed as type 2 diabetes mellitus since ten years duration wereincluded in the study. Retinopathy was graded into background, pre proliferative and proliferativeretinopathy. Type 2 diabetes was diagnosed using the WHO criteria. Statistical analysis was carried outusing the SPSS-11. Results: Diabetic retinopathy was found in 25.5% of the total Type 2 patients afterten years of diagnosis, and of these 4% of patients had proliferative retinopathy. Conclusion: Type 2diabetic patients should be screened as early as possible to prevent permanent visual loss by timelymanagement of diabetic retinopathy because diabetes is one of most common preventable cause ofblindness in the world.Keywords: Retinopathy, Type 2 DiabetesReferences
Tahir I, Jamal Z. Frequency of retinopathy in newly
diagnosed type 2 diabetes mellitus. Rawal Med J
;34(2):107–9.
Kalvoda B. Screening for diabetic retinopathy in Czech.
Republic- guidelines. Cesk Slov Oftalmol 2002;58:3–10.
Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B,
McCarty DJ, et al. Aus Diab Study Group. The prevalence of
and factors associated with diabetic retinopathy in Australian
population. Diabetes Care 2003;26:1731–7.
Wahid S, Mehmood N, Shaikh Z, Kazmi H. Frequency of
retinopathy in newly diagnosed type 2 diabetes patient. J Pak
Med Assoc 2008;58:557–61.
Lalit D, Rakhi D, Thomas J, Catherine A, Gullapali N.
Population based assessment of diabetic retinopathy in an
urban population in southern India. Br J Ophthalmol
;83:937–40.
Tayyab A, Nadeem Q, Khalid S. Screening for Diabetic
Retinopathy: a comparative study between hospital and
community based screening and between paying and non-paying
patients. J Ayub Med Coll Abottabad 2007;19(1):16–22.
Beulens JW, Patel A, Vingerling JR, Cruickshank JK,
Hughes AD, Stanton A, et al. Effects of blood pressure
lowering and intensive glucose control on the incidence and
progression of retinopathy in patients with type 2 diabetes
mellitus: a randomised controlled trial. Diabetologia
;52:2027–36.
Azizul H, Zaffar U, Mohammad Z, Sultan Z, Sobia S.
Awareness diabetic retinopathy amongst known diabetic. J
Postgrad Med Inst 2007;21(1):10–5.
World Health Organization. The WHO diagnostic criteria of
Diabetes of 1999 as revised in 2006 at the 19th World
Diabetes Conference [Internet]. [updated 2009]. Available at:
http:// www.who.int/Diabetes/publications/en.
Daniel E, Jerry D, George. Diabetic Retinopathy. Diabetes
Care 2002;25(Suppl-1):90–3.
Gonzalez EL, Johansson S, Wallander MA, Rodríguez LA.
Trends in the prevalence and incidence of diabetes in the UK:
-2005. J Epidemiol Community Health 2009;63:332–6.
Chew EY, Ambrosius WT, Davis MD, Danis RP,
Gangaputra S, Greven CM, et al. Effects of medical therapies
on retinopathy progression in type 2 diabetes. N Engl J Med
;363:233–44.
Mahar P, Zahid M, Nabeel M, Saleh. Prevalence of Type-II
Diabetes Mellitus and Diabetic Retinopathy: The Gaddap
Study J Coll Physicians Surg Pak 2010;20:528–32.
Ronald K, Barbara E, Scot E, Matthew D, David L.
Glycosylated Hemoglobin Predicts the Incidence and
Progression of Diabetic Retinopathy. JAMA
;260:2864–71.
Abramoff MD, Reinhardt JM, Russell SR, Folk JC, Mahajan
VB, Niemeijer M, et al. Automated early detection of
diabetic retinopathy. Ophthalmology 2010;117:1147–54.
Scotland GS, McNamee P, Philip S, Fleming AD, Goatman
KA, Prescott GJ, et al. Cost-effectiveness of implementing
automated grading within the national screening programme
for diabetic retinopathy in Scotland. Br J Ophthalmol
;91:1518–23.
West SD, Groves DC, Lipinski HJ, Nicoll DJ, Mason RH,
Scanlon PH, et al. The prevalence of retinopathy in men with
Type 2 diabetes and obstructive sleep apnoea. Diabet Med
;27:423–30.
Rohit V, Farzana C, Ronald K, Jassica C, Mina T, Stanel P.
Four-Year Incidence and Progression of Diabetic retinopathy
and Macular Edema: The Los Angeles Latino Eye Study.
Am J Ophthalmol 2010;149:752–61.
Klein R, Klein BE, Moss SE, Cruickshanks KJ.. The
Wisconsin Epidemiologic Study of Diabtic Retinopathy. TenYear Incidence and Progression of Diabetic Retinopathy.
Arch Ophthalmol 1994;112:1217–28.
Ronald K, Barbara E, Scot E, Matthew D, David L. The
Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Arch Ophthalmol 1984;102:520–6.
Nancy M, Fang B, Arghavan A, David C. Ischemic Diabetic
Retinopathy May Protect against Nuclear Sclerotic Cataract.
Am J Ophthalmol 2010;150:543–50.
Jermy D. Amy Z, Ronald K. Retinopathy in Nondiabetic
Persons with the Metabolic Syndrome: Findings from the
Third National Health and Nutrition Examination Survey.
Am J Ophthalmol 2009;147:934–44.
Can Supplements Help People With Diabetes Avoid
Retinopathy? Available at: http://www.sciencedaily.com/
releases/2010/01/100104104823.htm.
Management of type 2 diabetes. Retinopathy - screening and
early management, 2002.
http://www.nice.org.uk/guidance/index.jsp?action=byID&r=t
rue&o=10910NICE
Type 2 diabetes: the management of type 2 diabetes, 2009.
Available at: http://www.nice.org.uk/nicemedia/pdf/
CG87NICEGuideline.pdf
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
